CPT® Code 91302

Deleted

1. Indications

The vaccine represented by CPT® Code 91302 is indicated for the prevention of COVID-19, a disease caused by the SARS-CoV-2 virus. It is specifically recommended for individuals aged 18 years and older, who are at risk of contracting the virus and potentially developing severe and life-threatening complications associated with the disease.

• COVID-19 Prevention The vaccine is intended to provide immunity against the SARS-CoV-2 virus, thereby reducing the risk of severe illness and complications from COVID-19.

2. Procedure

The administration of the vaccine involves several key procedural steps that ensure proper delivery and effectiveness. Each step is crucial for achieving the desired immune response.

• Step 1: Preparation Prior to administration, the vaccine must be prepared according to the manufacturer's guidelines. This includes ensuring that the vaccine is at the appropriate temperature and that the vial is inspected for any particulate matter or discoloration.
• Step 2: Patient Assessment The healthcare provider should conduct a thorough assessment of the patient, including a review of their medical history and any potential contraindications to vaccination. This step is essential to ensure the safety and appropriateness of the vaccine for the individual.
• Step 3: Administration The vaccine is administered via intramuscular injection, typically in the deltoid muscle of the upper arm. The injection site should be cleaned with an antiseptic wipe before the injection to minimize the risk of infection.
• Step 4: Post-Administration Monitoring After the vaccine is administered, the patient should be monitored for a short period to observe for any immediate adverse reactions. This monitoring is critical to ensure patient safety and to provide prompt care if necessary.

3. Post-Procedure

Following the administration of the vaccine, patients may experience common side effects such as soreness at the injection site, mild fever, fatigue, or headache. These effects are typically short-lived and resolve within a few days. Patients should be advised to report any unusual or severe reactions to their healthcare provider. Additionally, it is important to inform patients about the need for a second dose if applicable, as well as the importance of continuing to follow public health guidelines to prevent the spread of COVID-19, even after vaccination.